Literature DB >> 20135288

Zymography and reverse zymography for detecting MMPs and TIMPs.

Susan P Hawkes1, Hongxia Li, Gary T Taniguchi.   

Abstract

Zymography is the electrophoretic separation of proteins through a polyacrylamide gel containing a proteolytic substrate. After denaturing (but nonreducing) electrophoresis, proteins are renatured and incubated in an appropriate buffer for proteolytic activity. Clear zones of lysis in the stained gel indicated active proteinases. Reverse zymography is a similar technique to detect proteinase inhibitors. After renaturing of proteins, the gel is incubated with metalloproteinases which digest the substrate incorporated into the gel. Inhibitors are shown as dark zones of inhibition against a clear background upon staining.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20135288     DOI: 10.1007/978-1-60327-299-5_16

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  29 in total

1.  Effects of cardiotonic steroids on trabecular meshwork cells: search for mediator of ouabain-enhanced outflow facility.

Authors:  Ang Li; Juni Banerjee; Kim Peterson-Yantorno; W Daniel Stamer; Chi Ting Leung; Mortimer M Civan
Journal:  Exp Eye Res       Date:  2012-01-24       Impact factor: 3.467

2.  Temperature oscillations drive cycles in the activity of MMP-2,9 secreted by a human trabecular meshwork cell line.

Authors:  Stanley Ka-Lok Li; Juni Banerjee; Christopher Jang; Amita Sehgal; Richard A Stone; Mortimer M Civan
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-02-05       Impact factor: 4.799

3.  Reverse zymography alone does not confirm presence of a protease inhibitor.

Authors:  Sangita Dutta; Debasish Bhattacharyya
Journal:  Protein J       Date:  2013-03       Impact factor: 2.371

Review 4.  Matrix metalloproteinases in the brain and blood-brain barrier: Versatile breakers and makers.

Authors:  Ralf G Rempe; Anika M S Hartz; Björn Bauer
Journal:  J Cereb Blood Flow Metab       Date:  2016-06-20       Impact factor: 6.200

5.  Functional characterisation of a novel mutation affecting the catalytic domain of MMP2 in siblings with multicentric osteolysis, nodulosis and arthropathy.

Authors:  Jacopo Azzollini; Davide Rovina; Cristina Gervasini; Ilaria Parenti; Alessia Fratoni; Maria Vittoria Cubellis; Amilcare Cerri; Luca Pietrogrande; Lidia Larizza
Journal:  J Hum Genet       Date:  2014-10-02       Impact factor: 3.172

6.  Synergistic effects of arsenic trioxide and silibinin on apoptosis and invasion in human glioblastoma U87MG cell line.

Authors:  Majid Zaki Dizaji; Mohsen Malehmir; Ardeshir Ghavamzadeh; Kamran Alimoghaddam; Seyed H Ghaffari
Journal:  Neurochem Res       Date:  2011-10-04       Impact factor: 3.996

7.  Therapeutic efficacy of silibinin on human neuroblastoma cells: Akt and NF-κB expressions may play an important role in silibinin-induced response.

Authors:  Meysam Yousefi; Seyed H Ghaffari; Bahram M Soltani; Shahriar Nafissi; Majid Momeny; Ali Zekri; Mehrdad Behmanesh; Kamran Alimoghaddam; Ardeshir Ghavamzadeh
Journal:  Neurochem Res       Date:  2012-06-21       Impact factor: 3.996

8.  Hydrogel crosslinking density regulates temporal contractility of human embryonic stem cell-derived cardiomyocytes in 3D cultures.

Authors:  Cindy Chung; Erica Anderson; Renee Reijo Pera; Beth L Pruitt; Sarah C Heilshorn
Journal:  Soft Matter       Date:  2012-08-21       Impact factor: 3.679

9.  Novel proteolytic microvesicles released from human macrophages after exposure to tobacco smoke.

Authors:  Chun-Jun Li; Yu Liu; Yan Chen; Demin Yu; Kevin Jon Williams; Ming-Lin Liu
Journal:  Am J Pathol       Date:  2013-03-13       Impact factor: 4.307

10.  Cardiomyopathy in the dystrophin/utrophin-deficient mouse model of severe muscular dystrophy is characterized by dysregulation of matrix metalloproteinases.

Authors:  Dawn A Delfín; Kara E Zang; Kevin E Schill; Nikita T Patel; Paul M L Janssen; Subha V Raman; Jill A Rafael-Fortney
Journal:  Neuromuscul Disord       Date:  2012-06-29       Impact factor: 4.296

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.